The effect of vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide on tolerance to morphine and alcohol in mice

被引：8
|
作者：
Szabó, G [1 ]
Mácsai, M [1 ]
Schek, É [1 ]
Telegdy, G [1 ]
机构：
[1] Albert Szent Gyorgyi Med Univ, Dept Pathophysiol, H-6701 Szeged, Hungary
来源：
VIP, PACAP, AND RELATED PEPTIDES: THIRD INTERNATIONAL SYMPOSIUM | 1998年 / 865卷
关键词：
D O I：
10.1111/j.1749-6632.1998.tb11238.x
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：566 / 569
页数：4
相关论文
共 50 条
  • [1] Special issue - Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide - Introduction
    Vaudry, Hubert
    PEPTIDES, 2007, 28 (09)
  • [2] The effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on morphine analgesia and morphine tolerance in mice
    Onou, Tetsuya
    Shimizu, Takao
    Sakamoto, Hikaru
    Higashi, Mikiko
    Kanmura, Yuichi
    Miyata, Atsuro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 230P - 230P
  • [3] Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer
    Moody, Terry W.
    Nuche-Berenguer, Bernardo
    Jensen, Robert T.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2016, 23 (01) : 38 - 47
  • [4] PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, HELOSPECTIN, AND VASOACTIVE INTESTINAL POLYPEPTIDE IN HUMAN CORPUS CAVERNOSUM
    HEDLUND, P
    ALM, P
    EKSTROM, P
    FAHRENKRUG, J
    HANNIBAL, J
    HEDLUND, H
    LARSSON, B
    ANDERSSON, KE
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (04) : 2258 - 2266
  • [5] Effect of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on mouse preantral follicle development in vitro
    Cecconi, S
    Rossi, G
    Barberi, M
    Scaldaferri, L
    Canipari, R
    ENDOCRINOLOGY, 2004, 145 (04) : 2071 - 2079
  • [6] Comparative distribution of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide immunoreactivity in the chicken forebrain
    Peeters, K
    Berghman, LR
    Vandesande, F
    TRENDS IN COMPARATIVE ENDOCRINOLOGY AND NEUROBIOLOGY: FROM MOLECULAR TO INTEGRATIVE BIOLOGY, 1998, 839 : 417 - 419
  • [7] Comparison between vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide levels in neuroblastoma tumour tissues
    Vertongen, P
    DeClerck, P
    Fournet, JC
    Martelli, H
    Helardot, P
    Devalck, C
    Peeters, T
    Sariban, E
    Robberecht, P
    NEUROPEPTIDES, 1997, 31 (05) : 409 - 413
  • [8] COMPARATIVE DISTRIBUTION OF IMMUNOREACTIVE PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE AND VASOACTIVE INTESTINAL POLYPEPTIDE IN RAT FOREBRAIN
    KOVES, K
    ARIMURA, A
    GORCS, TG
    SOMOGYVARIVIGH, A
    NEUROENDOCRINOLOGY, 1991, 54 (02) : 159 - 169
  • [9] Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation
    Hashimoto, H
    Ogawa, N
    Hagihara, N
    Yamamoto, K
    Imanishi, K
    Nogi, H
    Nishino, A
    Fujita, T
    Matsuda, T
    Nagata, S
    Baba, A
    MOLECULAR PHARMACOLOGY, 1997, 52 (01) : 128 - 135
  • [10] Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: Actions on the anterior pituitary gland
    Rawlings, SR
    Hezareh, M
    ENDOCRINE REVIEWS, 1996, 17 (01) : 4 - 29
12345